FDA Grants Fast Track to ALLO-329 for Scleroderma Treatment
This week's must-know community updates, latest research & events
Apply now: feature your voice in our cell and gene therapy series
Autoantibodies Influence Scleroderma Course
CCL2 Gene Identified as Common Biomarker in SSc and IPF
High Pigf Levels Linked to Scleroderma Renal Crisis in Patients, Study Finds
Emerging Treatments in Systemic Sclerosis-Associated Interstitial Lung Disease
Living with Chronic Gastrointestinal Issues Due to Scleroderma
Late-Onset ILD in Scleroderma: A Call for Continued Vigilance
Soquelitinib Shows Promise in Treating Lung Disease in Preclinical Trial
